611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

NurseWise 24-Hour Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

NurseWise 24-Hr Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Cancer
Resources
Basic InformationLatest News
ACOG: Shared Decision-Making Key to Breast Cancer ScreeningDrug, Herb Interactions Frequent for Cancer PatientsMany With Advanced Cancer Want Secondary Germline Findings InfoSecondhand Smoke Still Plagues Some Cancer SurvivorsBig Gap in Cancer Deaths Between Rich, Poor CountriesMany Doctors Silent on Cost of Cancer CareFamily Hx, Mutation Position Key Variables in BRCA1/2 Cancer RiskWeight-Loss Program Aids Black Breast Cancer SurvivorsWhen Is Risk Highest for Women With Breast Cancer Gene Mutations?Could Certain Hair Dyes, Relaxers Raise Breast Cancer Risk?Childhood Chemo May Have Lasting Effects on MemoryNovel Biomarkers Identified for Prostate Cancer in Non-BlacksModified Colorectal CA Screening Score Improves Risk PredictionRisk of HPV-Linked Second Cancers Up After Anal Cancer'Couch Potatoes' May Face Higher Risk of Kidney, Bladder CancersHealth Tip: Help Prevent Skin CancerWith Summer Sun Comes Heightened Skin Cancer RiskYoung CA Survivors More Often Have Cost-Related NonadherenceCertain Cancer Diagnoses Up in High-Income Counties in U.S.Liver Cancer the Fastest-Growing Cause of Cancer Deaths in U.S.Is Full Lymph Node Removal Always Needed for Melanoma?More Cancers Caught in Wealthy PeopleNurse-Led Psych Intervention Beneficial in Breast CancerU.S. Liver Cancer Deaths Have Doubled Since 1980s: StudyASCO: Industry Perks Influence Physicians' Choice of Cancer RxASCO: SWOG Trials Have Had Considerable Impact on CancerASCO: CAR T-Cell Therapy Promising in Multiple MyelomaPublicly Funded Cancer Trials Gained Americans 3 Million More YearsCan Drug Company Perks Sway Cancer Docs' Prescriptions?ASCO: Abiraterone Extends Survival in Metastatic Prostate CAASCO: Gene-Targeted Drug Shows Efficacy for Child, Adult CancersGene-Based Therapy May Thwart a Tough Blood CancerGene-Targeted Drugs Fight Advanced Lung CancersCancer Drug Helps Some Kids With Rare Type of LeukemiaDrug Helps Fight Breast Tumors Tied to 'Cancer Genes'Reporting Symptoms Online to Docs Helps Cancer Patients Live LongerDrug Extends Lives of Patients With Advanced Prostate Cancer: StudiesPregnancy Doesn't Raise Odds for Breast Cancer's ReturnExperimental Gene-Targeted Drug Hits Cancer Where It LivesChildhood Cancer Survivors Now Living Healthier LivesConquering One Big Cancer Side Effect: FearDark Skin No Shield From Deadly Skin CancerCertain Breast CA Patients Benefit From Adjuvant CapecitabineDrug Xeloda Prolongs Survival for Some Breast Cancer PatientsHigh Costs for Myeloma Patients Not Getting Low-Income SubsidyDaily Texting Effectively Monitors Rx Adherence, Side EffectsScientists Report Progress on Genetic Test for Anal CancerLocation of Body Fat Can Indicate Obesity-Related Cancer RiskBlood Test for Earlier Detection of Pancreatic Cancer FeasibleSocial Contagion Impacts Imaging Use in Breast Cancer
LinksBook ReviewsSelf-Help Groups
Related Topics

Medical Disorders
Pain Management

Counseling Visit Helps Patients Decide About Lung CA Screening


HealthDay News
Updated: Mar 20th 2017

new article illustration

MONDAY, March 20, 2017 (HealthDay News) -- A centralized counseling and shared decision-making visit correlates with improvement in patient knowledge about eligibility criteria, benefits, and harms of low-dose computed tomography (LDCT) lung cancer screening, according to a study published in the March issue of CHEST.

Peter J. Mazzone, M.D., M.P.H., from the Cleveland Clinic, and colleagues developed a centralized counseling and shared decision-making visit for a lung cancer screening program, which included confirmation of eligibility for screening, education, individualized risk assessment, time for questions, and data collection. Patients were surveyed before, immediately after, and at one month after the visit.

The researchers found that 5.4 percent of the 423 patients who had a visit did not proceed to CT screening. Overall, 125, 122, and 113 patients completed the initial, post-visit, and follow-up surveys, respectively. Patients had a poor level of understanding about the age and smoking eligibility criteria before the visit (8.8 and 13.6 percent correct, respectively) and about the benefits and harms of screening (55.2 and 38.4 percent correct, respectively). After the visit there was a significant improvement in knowledge for all questions (P = 0.03 to P < 0.0001). By the one-month follow-up, knowledge had waned, but it remained higher than before the visit.

"A centralized counseling and shared decision-making visit impacts the patient's knowledge about the eligibility criteria, benefits, and harms of lung cancer screening with LDCT, helping patients make value-based decisions," the authors write.

Abstract/Full Text (subscription or payment may be required)